Addiction   

For your recommended medication, are you doing a scheduled set dose, or is it primarily symptom-driven? 

In what patient populations would you consider using disulfiram (Antabuse) instead of, or in addition to, acamprosate or naltrexone? In your experienc...

Assume QTc is not prolonged, electrolytes are reasonably normal, and the patient is not already on heavy psychotropic polypharmacy.

If so, in what settings or with which patient populations? What is the evidence for or against this treatment modality?

Do you ever incorporate it into treatment, and if so, in what clinical contexts?

Do you support vaping as a harm reduction strategy? What alternatives do you recommend if patients are ambivalent about FDA-approved cessation medicat...

Is there an absolute cutoff for AST/ALT that you use where the risks outweigh the potential harm reduction benefits of using the medication? &nbs...

This is based on the recent publication by Bernstein et al., PMID 38551564 which investigated the increased rate of initiation of MAUD in the hospital...

(E.g., test taking, performance at work)

In light of Straub et al's comparative study of combination vs buprenorphine alone

Are any effective options available beyond nicotine replacement therapy, varenicline, or bupropion?

For example, related to psilocybin or synthetic THC?

What DSM-5 diagnosis and or diagnostic code do you use when treating this substance use disorder?

Is there evidence for the use of varenicline, bupropion, or other medication therapies to assist in tobacco vaping cessation?